feed,title,long_url,short_url
Benzinga,ConforMIS Spikes On Australian Approval News,https://benzinga.com/news/21/03/19933811/conformis-spikes-on-australian-approval-news,https://j.mp/3sFcqPA
Benzinga,ROCE Insights For Nike,https://benzinga.com/news/earnings/21/03/19942321/roce-insights-for-nike,https://j.mp/3sL7oAX
Benzinga,Looking Into Akebia Therapeutics's Return On Capital Employed,https://benzinga.com/news/earnings/21/03/19942288/looking-into-akebia-therapeuticss-return-on-capital-employed,https://j.mp/384ps1b
Benzinga,Return On Capital Employed Overview: Crocs,https://benzinga.com/news/earnings/21/03/19942280/return-on-capital-employed-overview-crocs,https://j.mp/3dZMzOj
Benzinga,ROCE Insights For Novavax,https://benzinga.com/news/earnings/21/03/19942272/roce-insights-for-novavax,https://j.mp/2Prw17D
Benzinga,Looking Into Tesla's Return On Capital Employed,https://benzinga.com/news/earnings/21/03/19942266/looking-into-teslas-return-on-capital-employed,https://j.mp/2Of4Jka
Benzinga,Looking Into JELD-WEN Holding's Return On Capital Employed,https://benzinga.com/news/earnings/21/03/19942227/looking-into-jeld-wen-holdings-return-on-capital-employed,https://j.mp/3uLTDns
Benzinga,Return On Capital Employed Overview: Switch,https://benzinga.com/news/earnings/21/03/19942205/return-on-capital-employed-overview-switch,https://j.mp/306eyna
